Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$252,300
-$25,603 QoQ
Shares Held
1,997
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,779
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobsen Capital Management holds $5,455,034 across 7 Drug Manufacturers - General names. GILD ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,543 | $1,850,720 | |
| 2 | JNJ |
Johnson & Johnson
|
4,712 | $1,196,706 | |
| 3 | ABBV |
AbbVie Inc.
|
3,660 | $921,002 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,798 | $616,543 | |
| 5 | AMGN |
Amgen Inc
|
1,011 | $366,103 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,997 | $252,300 | |
| 7 | PFE |
Pfizer Inc
|
10,451 | $251,660 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,300 | 1,997 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $277,903 | 1,994 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $244,743 | 1,994 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $223,776 | 2,016 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $223,735 | 2,018 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||